M

MindRank

HealthGLP-1 Drug Development

MindRank is a biotechnology company focused on developing GLP-1 drugs. This funding round will help advance their innovative treatments aimed at addressing metabolic disorders. The $52 million raised will support their clinical trials and further research.

Visit website ↗
Total raised
$52M
tracked to date
Latest round
Series B
Jul 10, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $52MSeries BJul 10, 2026
    Announcement ↗

MindRank in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile